bead-based simoa (Quanterix)
Quanterix is a verified supplier 
Quanterix manufactures this product 
90
Structured Review
Quanterix
bead-based simoa
Bead Based Simoa, supplied by Quanterix, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bead-based+simoa/pmc11095038-4-4-0
Average 90 stars, based on 1 article reviews
Bead Based Simoa, supplied by Quanterix, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bead-based+simoa/pmc11095038-4-4-0
Average 90 stars, based on 1 article reviews
bead-based simoa - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Biomarker Assay:Article Title: Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reporting Article Snippet: Article Title: Biomarker changes preceding symptom onset in genetic prion disease Article Snippet: Biomarker assays utilized were: RT-QuIC (IQ-CSF protocol) , Article Title: Comparative methods for quantifying plasma biomarkers in Alzheimer's disease: Implications for the next frontier in cerebral amyloid angiopathy diagnostics. Article Snippet: University of Gothenburg Simoa (UGOT-Simoa); Meso Scale Discovery platform from Eli Lilly (MSD-Eli Lilly); IP-MSWashington University ((IP-MS-WashU); Splex immunoassay fromMeso Scale Discovery platform (MSD-Splex); Lumipulse immuno assay by Fujirebo (Lumipulse-Fujirebo); ADxNeurosciences Simoa (ADx Simoa); Simoa from Eli Lilly (EliLilly-Simoa); Simoa from Jansen (Jansen-Simoa); Article Title: Definition of a Threshold for the Plasma Aβ42/Aβ40 Ratio Measured by Single-Molecule Array to Predict the Amyloid Status of Individuals without Dementia Article Snippet: The plasma Aβ42/Aβ40 ratio was measured using Article Title: Fluid Biomarkers in Individuals at Risk for Genetic Prion Disease up to Disease Conversion Article Snippet: Biomarker assays used were RT-QuIC (IQ-CSF protocol), PrP ELISA (eFigure 2), Enzyme-linked Immunosorbent Assay:Article Title: Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reporting Article Snippet: Article Title: Biomarker changes preceding symptom onset in genetic prion disease Article Snippet: Biomarker assays utilized were: RT-QuIC (IQ-CSF protocol) , Article Title: Comparative methods for quantifying plasma biomarkers in Alzheimer's disease: Implications for the next frontier in cerebral amyloid angiopathy diagnostics. Article Snippet: University of Gothenburg Simoa (UGOT-Simoa); Meso Scale Discovery platform from Eli Lilly (MSD-Eli Lilly); IP-MSWashington University ((IP-MS-WashU); Splex immunoassay fromMeso Scale Discovery platform (MSD-Splex); Lumipulse immuno assay by Fujirebo (Lumipulse-Fujirebo); ADxNeurosciences Simoa (ADx Simoa); Simoa from Eli Lilly (EliLilly-Simoa); Simoa from Jansen (Jansen-Simoa); Article Title: Definition of a Threshold for the Plasma Aβ42/Aβ40 Ratio Measured by Single-Molecule Array to Predict the Amyloid Status of Individuals without Dementia Article Snippet: The plasma Aβ42/Aβ40 ratio was measured using Article Title: Fluid Biomarkers in Individuals at Risk for Genetic Prion Disease up to Disease Conversion Article Snippet: Biomarker assays used were RT-QuIC (IQ-CSF protocol), PrP ELISA (eFigure 2), Mass Spectrometry:Article Title: Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reporting Article Snippet: Article Title: Biomarker changes preceding symptom onset in genetic prion disease Article Snippet: Biomarker assays utilized were: RT-QuIC (IQ-CSF protocol) , Article Title: Comparative methods for quantifying plasma biomarkers in Alzheimer's disease: Implications for the next frontier in cerebral amyloid angiopathy diagnostics. Article Snippet: University of Gothenburg Simoa (UGOT-Simoa); Meso Scale Discovery platform from Eli Lilly (MSD-Eli Lilly); IP-MSWashington University ((IP-MS-WashU); Splex immunoassay fromMeso Scale Discovery platform (MSD-Splex); Lumipulse immuno assay by Fujirebo (Lumipulse-Fujirebo); ADxNeurosciences Simoa (ADx Simoa); Simoa from Eli Lilly (EliLilly-Simoa); Simoa from Jansen (Jansen-Simoa); Article Title: Definition of a Threshold for the Plasma Aβ42/Aβ40 Ratio Measured by Single-Molecule Array to Predict the Amyloid Status of Individuals without Dementia Article Snippet: The plasma Aβ42/Aβ40 ratio was measured using Article Title: Fluid Biomarkers in Individuals at Risk for Genetic Prion Disease up to Disease Conversion Article Snippet: Biomarker assays used were RT-QuIC (IQ-CSF protocol), PrP ELISA (eFigure 2), Immuno Assay:Article Title: Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reporting Article Snippet: Article Title: Biomarker changes preceding symptom onset in genetic prion disease Article Snippet: Biomarker assays utilized were: RT-QuIC (IQ-CSF protocol) , Article Title: Comparative methods for quantifying plasma biomarkers in Alzheimer's disease: Implications for the next frontier in cerebral amyloid angiopathy diagnostics. Article Snippet: University of Gothenburg Simoa (UGOT-Simoa); Meso Scale Discovery platform from Eli Lilly (MSD-Eli Lilly); IP-MSWashington University ((IP-MS-WashU); Splex immunoassay fromMeso Scale Discovery platform (MSD-Splex); Lumipulse immuno assay by Fujirebo (Lumipulse-Fujirebo); ADxNeurosciences Simoa (ADx Simoa); Simoa from Eli Lilly (EliLilly-Simoa); Simoa from Jansen (Jansen-Simoa); Article Title: Definition of a Threshold for the Plasma Aβ42/Aβ40 Ratio Measured by Single-Molecule Array to Predict the Amyloid Status of Individuals without Dementia Article Snippet: The plasma Aβ42/Aβ40 ratio was measured using Article Title: Fluid Biomarkers in Individuals at Risk for Genetic Prion Disease up to Disease Conversion Article Snippet: Biomarker assays used were RT-QuIC (IQ-CSF protocol), PrP ELISA (eFigure 2), High Throughput Screening Assay:Article Title: Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reporting Article Snippet: Article Title: Biomarker changes preceding symptom onset in genetic prion disease Article Snippet: Biomarker assays utilized were: RT-QuIC (IQ-CSF protocol) , Article Title: Comparative methods for quantifying plasma biomarkers in Alzheimer's disease: Implications for the next frontier in cerebral amyloid angiopathy diagnostics. Article Snippet: University of Gothenburg Simoa (UGOT-Simoa); Meso Scale Discovery platform from Eli Lilly (MSD-Eli Lilly); IP-MSWashington University ((IP-MS-WashU); Splex immunoassay fromMeso Scale Discovery platform (MSD-Splex); Lumipulse immuno assay by Fujirebo (Lumipulse-Fujirebo); ADxNeurosciences Simoa (ADx Simoa); Simoa from Eli Lilly (EliLilly-Simoa); Simoa from Jansen (Jansen-Simoa); Article Title: Definition of a Threshold for the Plasma Aβ42/Aβ40 Ratio Measured by Single-Molecule Array to Predict the Amyloid Status of Individuals without Dementia Article Snippet: The plasma Aβ42/Aβ40 ratio was measured using Article Title: Fluid Biomarkers in Individuals at Risk for Genetic Prion Disease up to Disease Conversion Article Snippet: Biomarker assays used were RT-QuIC (IQ-CSF protocol), PrP ELISA (eFigure 2), Positron Emission Tomography:Article Title: Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reporting Article Snippet: Article Title: Biomarker changes preceding symptom onset in genetic prion disease Article Snippet: Biomarker assays utilized were: RT-QuIC (IQ-CSF protocol) , Article Title: Comparative methods for quantifying plasma biomarkers in Alzheimer's disease: Implications for the next frontier in cerebral amyloid angiopathy diagnostics. Article Snippet: University of Gothenburg Simoa (UGOT-Simoa); Meso Scale Discovery platform from Eli Lilly (MSD-Eli Lilly); IP-MSWashington University ((IP-MS-WashU); Splex immunoassay fromMeso Scale Discovery platform (MSD-Splex); Lumipulse immuno assay by Fujirebo (Lumipulse-Fujirebo); ADxNeurosciences Simoa (ADx Simoa); Simoa from Eli Lilly (EliLilly-Simoa); Simoa from Jansen (Jansen-Simoa); Article Title: Definition of a Threshold for the Plasma Aβ42/Aβ40 Ratio Measured by Single-Molecule Array to Predict the Amyloid Status of Individuals without Dementia Article Snippet: The plasma Aβ42/Aβ40 ratio was measured using Article Title: Fluid Biomarkers in Individuals at Risk for Genetic Prion Disease up to Disease Conversion Article Snippet: Biomarker assays used were RT-QuIC (IQ-CSF protocol), PrP ELISA (eFigure 2), |